MDxHealth « Terug naar discussie overzicht

Overname MdxHeallth is al een feit ?

125 Posts, Pagina: « 1 2 3 4 5 6 7 » | Laatste
lisja
0
Zou fijn zijn wanneer er recentere berichten zijn. 2015 is wel heel ver weg, info over 2017 en volgende jaren zitte we met zijn allen meer op te wachten dacht ik zo.
[verwijderd]
0
Het momentum is aanstaande.

MdxHealth wordt de kalkoen van Exact Sciences voor de kerst !

Ben benieuwd naar overnamebod.

70% premie op gedirigeerde koers van 4,50 euro.
[verwijderd]
0
Ik hoop dat je gelijk krijgt.
De vraag is heb je liever gelijk of ben je liever gelukkig.
Rotel74
0
quote:

inspirator schreef op 20 december 2016 16:41:

Eerste bod is dan 7,65 euro per aandeel MdxHealth
Rekenkundig ok! Nu de rest nog
[verwijderd]
0
quote:

inspirator schreef op 20 december 2016 16:41:

Eerste bod is dan 7,65 euro per aandeel MdxHealth
Nog 1/2 uur tijd om 70% rendement te maken binnen 16 uur tijd !
Rotel74
0
"..en dan wordt oma een beetje giechelig...en mag ik laat naar bed ..." uit Lidl-Tv-kerstreklame
[verwijderd]
0
Mr. Roelandt joins MDxHealth after having served as Chief Financial Officer and Managing Director at BHF Kleinwort Benson (previously known as RHJ International) since 2006. In addition to his responsibilities as a member of BHF Kleinwort Benson Group's executive management, he was also appointed Executive Director and Chief Financial Officer of Kleinwort Benson Bank in London from July 2015 until the acquisition of the BHF Kleinwort Benson Group by Oddo & Cie in 2016.

Jean-Marc Roelandt was ook kortstondig directeur (tot overname) bij voorgaande werkgever.

De vette vis MdxHealth gaat bijten.
[verwijderd]
0
Amerikaanse biotechaandelen omlaag na opmerkingen Trump

Exact Sciences reageert niet op Trump zijn uitspraken, gewoon in de plus: www.nasdaq.com/symbol/exas

Was Jan Groen maar de broer van Donald Trump.

Of mag hij niet spreken ivm overnamebespreking met Exact Sciences ?
[verwijderd]
0
quote:

inspirator schreef op 11 januari 2017 19:52:

Amerikaanse biotechaandelen omlaag na opmerkingen Trump

Exact Sciences reageert niet op Trump zijn uitspraken, gewoon in de plus: www.nasdaq.com/symbol/exas

Was Jan Groen maar de broer van Donald Trump.

Of mag hij niet spreken ivm overnamebespreking met Exact Sciences ?
Exact Sciences has healthy results

Finally, Exact Sciences gained 19%. The maker of the Cologuard colon-cancer screening test gave preliminary fourth-quarter results, predicting that it would report sales of between $34.9 million and $35.4 million. That would be up more than 140% from year-ago levels, and Exact Sciences said it performed about 82,000 Cologuard tests during the quarter, more than double what it did during the same period in 2015. Progress in getting new healthcare providers and insurance companies to embrace the test had Exact Sciences CEO Kevin Conroy proclaiming that, "Cologuard is becoming a standard of care for 80 million Americans who should be screened for colon cancer." Final results won't be available until February, but investors are convinced that Exact Sciences is on exactly the right path toward success.

Read more: www.fool.com/investing/2017/01/09/why...
[verwijderd]
0
quote:

inspirator schreef op 11 januari 2017 19:58:

[...]

Exact Sciences has healthy results

Finally, Exact Sciences gained 19%. The maker of the Cologuard colon-cancer screening test gave preliminary fourth-quarter results, predicting that it would report sales of between $34.9 million and $35.4 million. That would be up more than 140% from year-ago levels, and Exact Sciences said it performed about 82,000 Cologuard tests during the quarter, more than double what it did during the same period in 2015. Progress in getting new healthcare providers and insurance companies to embrace the test had Exact Sciences CEO Kevin Conroy proclaiming that, "Cologuard is becoming a standard of care for 80 million Americans who should be screened for colon cancer." Final results won't be available until February, but investors are convinced that Exact Sciences is on exactly the right path toward success.

Read more: www.fool.com/investing/2017/01/09/why...
Exact Sciences inmiddels wederom 6% hogere koers.
[verwijderd]
0
Kevin Conroy
don't matter who is in the Whitehouse, cancer stays a killer
detectiontechnology is going to change the world !

video.foxbusiness.com/v/5275444224001...

Geweldig interview met CEO Exact Sciences over Cologuard.
Cologuard; dna technology MdxHealth inside.
[verwijderd]
0
quote:

inspirator schreef op 11 januari 2017 23:47:

Kevin Conroy
don't matter who is in the Whitehouse, cancer stays a killer
detectiontechnology is going to change the world !

video.foxbusiness.com/v/5275444224001...

Geweldig interview met CEO Exact Sciences over Cologuard.
Cologuard; dna technology MdxHealth inside.
Nog taal nog teken van CEO MdxHealth.

Jan Groen presenteert MdxHealth onvoldoende.

Neem een voorbeeld aan Kevin Conroy.

Inmiddels koers MdxHealthal 10% gedaald na 'stille' update afgelopen maandag met super goede vooruitzichten.

Een goede uitspraak van Jan Groen en koers staat boven 5 euro.

Jan Groen; be good en tell the world !
[verwijderd]
0
quote:

inspirator schreef op 11 januari 2017 23:47:

Kevin Conroy
don't matter who is in the Whitehouse, cancer stays a killer
detectiontechnology is going to change the world !

video.foxbusiness.com/v/5275444224001...

Geweldig interview met CEO Exact Sciences over Cologuard.
Cologuard; dna technology MdxHealth inside.
Exact Sciences wederom 2% in de plus.

Wat een geweldenaar is dat toch die Kevin Conroy.

Kan niet wachten op takeoverbid van Exact Sciences op MdxHealth.

Een aandelenruil van 1 Exact Sciences aandeel tegen 1 MdxHealth aandeel is oke.
[verwijderd]
0
quote:

inspirator schreef op 10 januari 2017 18:45:

Mr. Roelandt joins MDxHealth after having served as Chief Financial Officer and Managing Director at BHF Kleinwort Benson (previously known as RHJ International) since 2006. In addition to his responsibilities as a member of BHF Kleinwort Benson Group's executive management, he was also appointed Executive Director and Chief Financial Officer of Kleinwort Benson Bank in London from July 2015 until the acquisition of the BHF Kleinwort Benson Group by Oddo & Cie in 2016.

Jean-Marc Roelandt was ook kortstondig directeur (tot overname) bij voorgaande werkgever.

De vette vis MdxHealth gaat bijten.

Het (de overname van MdxHealth) gaat gebeuren.
125 Posts, Pagina: « 1 2 3 4 5 6 7 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 1 jan 0001
Koers 0,000
Verschil 0,000 (0,00%)
Hoog 0,000
Laag 0,000
Volume 0
Volume gemiddeld 0
Volume gisteren 0

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront